SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-019793
Filing Date
2020-10-22
Accepted
2020-10-22 13:27:43
Documents
160
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form20-f.htm 20-F 3174806
2 chart.jpg GRAPHIC 19124
3 ex4-1.htm EX-4.1 24042
4 ex12-01.htm EX-12.01 13261
5 ex12-02.htm EX-12.02 13343
6 ex13-01.htm EX-13.01 7619
7 ex13-02.htm EX-13.02 7664
8 ex15-1.htm EX-15.1 11173
9 ex15-2.htm EX-15.2 15197
10 ex15-2_001.jpg GRAPHIC 1878
11 ex15-2_002.jpg GRAPHIC 1877
  Complete submission text file 0001493152-20-019793.txt   11104048

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE gtg-20200630.xml EX-101.INS 2012600
13 XBRL SCHEMA FILE gtg-20200630.xsd EX-101.SCH 138400
14 XBRL CALCULATION FILE gtg-20200630_cal.xml EX-101.CAL 117282
15 XBRL DEFINITION FILE gtg-20200630_def.xml EX-101.DEF 341754
16 XBRL LABEL FILE gtg-20200630_lab.xml EX-101.LAB 669371
17 XBRL PRESENTATION FILE gtg-20200630_pre.xml EX-101.PRE 529631
Mailing Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065
Business Address 60-66 HANOVER STREET FITZROY, VICTORIA C3 3065 011613-9415-1135
GENETIC TECHNOLOGIES LTD (Filer) CIK: 0001166272 (see all company filings)

IRS No.: 000000000
Type: 20-F | Act: 34 | File No.: 000-51504 | Film No.: 201253695
SIC: 2836 Biological Products, (No Diagnostic Substances)